Molecular basis of muscle hypertrophy and atrophy: Potential therapy for muscular dystrophy
Naoki Ito, Yuko Miyagoe‐Suzuki, Shin’ichi Takeda
Tokyo Institute of Technology National Center of Neurology and Psychiatry National Institute of Neuroscience
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Skeletal muscle mass is regulated by a balance of protein synthesis and degradation. The regulation of this protein synthesis/degradation system is linked with muscle activity, and leads to muscle hypertrophy/atrophy. However, recent studies suggested that this system is also linked to the mechanisms underlying muscular dystrophy. In this review, we summarize the recent advances relating to the molecular mechanisms of the protein synthesis/degradation system, and overview the new therapeutic strategy for muscular dystrophy that targets the molecular events that regulate muscle hypertrophy/atrophy.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Muscle Physiology and Disorders
Muscle metabolism and nutrition · Metabolism, Diabetes, and Cancer